Literature DB >> 3354501

Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma.

S S Robey1, S R Hamilton, P K Gupta, Y S Erozan.   

Abstract

Barrett esophagus, the columnar-lined distal esophagus acquired as a consequence of chronic gastroesophageal reflux, is associated with the development of columnar epithelial dysplasia and esophageal adenocarcinoma. To determine the efficacy of cytopathology in identifying Barrett esophagus and related neoplasia, observations were compared on 150 esophageal cytology samples with concurrent endoscopic biopsy specimens. Sixty-six specimens that contained benign columnar epithelium in either cytologic or biopsy material were identified. Distinctive-type Barrett mucosa with incomplete intestinalization, considered diagnostic of Barrett esophagus, was found in 34 of 66 cases (52%) and was present only in cytologic material in 11 cases. Twenty-two specimens contained cardiac-type mucosa (present only in cytology in ten cases), a finding of uncertain significance due to lack of localization of the sample with respect to the gastroesophageal junction. Fundic-type mucosa was not observed in any specimen. Two cases of distinctive-type Barrett mucosa with columnar epithelial dysplasia were identified in both biopsy and cytology specimens. Among eight Barrett-associated carcinomas (seven adenocarcinomas and one squamous), cytologic material was diagnostic for malignancy in seven and highly suspicious in one. It was concluded that cytopathologic studies are a useful adjunct to biopsy histopathology in the diagnosis of Barrett esophagus and associated carcinoma. The role of cytopathology in the diagnosis of Barrett-related columnar epithelial dysplasia requires further study, and at present a cautious approach with biopsy confirmation is recommended.

Entities:  

Mesh:

Year:  1988        PMID: 3354501     DOI: 10.1093/ajcp/89.4.493

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Adenocarcinoma and Barrett's oesophagus.

Authors:  J Jankowski
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

2.  Screening, surveillance, and prevention for esophageal cancer.

Authors:  Yutaka Tomizawa; Kenneth K Wang
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

Review 3.  Screening for Barrett's Esophagus.

Authors:  Massimiliano di Pietro; Daniel Chan; Rebecca C Fitzgerald; Kenneth K Wang
Journal:  Gastroenterology       Date:  2015-02-17       Impact factor: 22.682

4.  Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study.

Authors:  Zhixiong Wang; Swetha Kambhampati; Yulan Cheng; Ke Ma; Cem Simsek; Alan H Tieu; John M Abraham; Xi Liu; Vishnu Prasath; Mark Duncan; Alejandro Stark; Alexander Trick; Hua-Ling Tsai; Hao Wang; Yulong He; Mouen A Khashab; Saowanee Ngamruengphong; Eun J Shin; Tza-Huei Wang; Stephen J Meltzer
Journal:  Clin Cancer Res       Date:  2019-01-22       Impact factor: 13.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.